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Abstract 
Previous work to develop biosensors that can be used to detect 
organophosphorus compounds (OPCs) has successfully demonstrated the potential 
application of enzymes encapsulated in peptide-nanotubes (PNTs) enhanced with 
horseradish peroxidase (HRP) to detect the presence of OPCs in the aqueous and gas 
phases (Stevens, 2012; Park et al., 2011a; 2012b; Baker, 2013).  This previous research 
demonstrated that PNTs provide more surface area for the enzyme-catalyzed chemical 
reaction; while HRP provides increased electrochemical sensitivity.  In this research, a 
standardized test method developed by Baker (2013), which was applied to evaluate a 
biosensor fabricated with a single-use electrode, was refined to accommodate a 
reusable screen printed electrode.  Also in this study, butyrylcholinesterase (BChE) 
enzyme was used in lieu of the acetylcholinesterase (AChE) enzyme applied in Baker’s 
(2013) study in an effort to enhance biosensor performance. 
Biosensor operation is based on the principle that butyrylthiocholine (BSCh), in 
the presence of the enzyme BChE, will produce a measurable electrochemical signal 
during chemical reaction; a signal that is inhibited in the presence of an OPC.  For this 
research, cyclic voltammograms (CVs) were used to measure the inhibition in current at a 
specified voltage due to the presence of a model OPC, malathion.  Inhibition of the signal 
produced by an AChE-based biosensor due to the presence of malathion was found to be 
proportional to the malathion concentration (Baker, 2013).  In the current study, the 
response of a BChE-based biosensor was also shown to be inhibited by gas phase 
malathion concentrations less than 25 ppbv, with the extent of inhibition linearly 
v 
proportional to the malathion concentration above 6 ppbv.  Additionally, this study 
demonstrated that a BChE-based biosensor stored at room temperature can be used as 
long as 42 days after fabrication.
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GAS PHASE ORGANOPHOSPHATE DETECTION USING ENZYMES 
ENCAPSULATED WITHIN PEPTIDE NANOTUBES 
I. Introduction 
Background 
Organophosphorus compounds (OPCs), among the most toxic substances known, 
are used as chemical warfare agents (CWAs), agricultural pesticides, and insecticides.  
For example, dimethyl methyl phosphonate (DMMP), an OPC, is used as a flame 
retardant and can result in non-lethal, deleterious effects such as nausea and/or vomiting 
after only a ten minute exposure to air concentrations as low as 0.005-0.01 mg/m
3
 (Goltz 
et al., 2011).  Because OPCs may cause harm at very low concentrations, sensitive, fast 
and accurate sensors are necessary to protect those potentially exposed.   
Current analytical techniques, such as gas and liquid chromatography, although 
very sensitive and reliable, have disadvantages.  The US Air Force currently uses a field 
portable gas chromatograph/mass spectrometer (GC/MS), Hazardous Air Pollutants on 
Site (HAPSITE), which is heavy, expensive, needs specially trained personnel to operate, 
and requires up to thirty minutes per single measurement (Goltz et al., 2011).  Long 
measurement times directly impact the ability to maintain mission readiness when 
responding to a chemical agent attack.  The Air Force standard for mission capability 
restoration is resumption of the primary mission within two hours of a chemical attack 
(USAF, 2003; USAF, 2011).  Clearly, if a chemical agent attack is suspected, there is a 
need to reduce the time between sampling and acquisition of actionable results (Goltz et 
al., 2011).   
2 
Time-consuming, expensive techniques performed by highly trained technicians 
are not suitable for most situations requiring immediate attention (Goltz et al., 2011).  
Disadvantages of current techniques have motivated investigators to search for more 
useful detection technologies (Liu and Lin, 2006).  The application of electrochemical 
biosensors for chemical agent detection is one promising avenue for development 
because these sensors are relatively simple to make and can be tailored to suit specific 
requirements (Upadhyayula, 2012).  Advancements in the nanotechnology field have 
resulted in the development of biosensors that are fabricated with peptide nanotubes 
(PNTs) to improve sensor performance (Berger, 2008).  Previously, a biosensor for the 
detection of OPCs in the aqueous phase was successfully demonstrated by encapsulating 
acetyl cholinesterase (AChE) enzyme on peptide nanotubes (PNTs) (Stevens, 2012).  
Research at the Air Force Institute of Technology (AFIT) (Baker, 2013) demonstrated the 
feasibility of reliable OPC detection in the gas phase at malathion concentrations as low 
as 12.5 ppbv utilizing horseradish peroxidase (HRP) encapsulated within PNTs, with the 
acetyl cholinesterase enzyme (AChE) on the outside of the PNT, on a single-use, gold 
screen-printed electrode (SPE) using Nafion as a protective layer (Figure 1).  Additional 
studies have shown that direct sensing of target chemicals can be accomplished by using 
highly sensitive biosensors (e.g., enzymes) with a strong affinity toward these target 
molecules (Arduini et al., 2007; Stevens, 2012; Park et al., 2011b; Baker, 2013; 
Upadhyay & Verma, 2013).   
Biosensor Construction and Operation  
Biosensors are a relatively new, inexpensive technology that can be used in situ to 
provide real time data.  While living systems control cellular function through an array of 
enzymes, biosensors can be constructed using a single enzyme as a highly selective 
3 
sensing agent.  Enzymatic reactions may be either reversible or irreversible (Arduini, 
2012a).  Also, although enzymes preferentially interact with their complementary 
compounds, they are vulnerable to degradation over time once fabricated and 
environmentally exposed.  Temperature, pH, and humidity may impact enzyme stability 
(Stevens, 2012; Baker, 2013).  Enzyme activity may be maintained by protecting the 
enzymes under Nafion or cellulose acetate layers and by storing in a properly controlled 
environment (Baker, 2013; Arduini et al., 2012a). 
In a recent review of OPC biosensor studies (Arduini et al., 2010), it was found 
that about ten percent of the studies involved testing sensors with a specific commercial 
application in mind; two papers explored OPC detection in the gas phase.  One set of 
experiments tested a Prussian blue silver screen printed electrode (SPE) using 
butyrylcholinesterase (BChE) as an enzyme and butyrylthiocholine (BSCh) as the 
substrate (Arduini et al., 2007).  In that study, cellulose acetate was utilized to preserve 
enzyme activity.    Inhibition of the BChE/BSCh reaction in the presence of Sarin (GB) 
gas was measured to indicate the GB presence (Arduini et al., 2007).  Since 2010, a 
number of studies have investigated gas phase detection of OPCs using sensors that 
incorporate nanomaterials.  Biosensor fabrication using nanomaterials allows for 
miniaturization, while maintaining sensitivity and decreased response time  when 
compared to the HAPSITE GC/MS detection process  (Alonso et al., 2011; Arduini and 
Palleschi, 2012b; Arduini et al., 2012a; 2013; Baker, 2013; Chen et al., 2012; Ju et al., 
2011; Wang et al., 2011).  Previous studies have successfully tested OPC detection one 
day after sensor fabrication, Arduini et al., 2007; 2010; Andreescu and Marty, 2006, and 
others have demonstrated sensor longevity of fifty days using vacuum seal techniques 
(Andreescu and Marty, 2006).  While Baker (2013) demonstrated successful single use 
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AChE biosensors, comparison of longevity under “normal” environmental laboratory 
conditions or electrode reusability were not considered.  This research explores the use of 
reusable SPEs in the fabrication of a BChE/BSCh biosensor using PNT nanomaterials to 
increase surface area/sensitivity while using HRP to lower electrical resistance and 
Nafion to extend longevity.  This particular fabrication and research approach is new and 
provides for baseline comparison. 
When the OPC malathion interacts with acetylcholinesterase (AChE), the chemical 
bonding process is irreversible (Arduini, 2012a).  Unlike AChE which resides between 
nerve cells and facilitates intercellular electrical impulses, butyrylcholinesterase (BChE) 
is created in the liver and circulates within the bloodstream (Evtugyn et al., 2013).  BChE 
has a high affinity for OPCs such as malathion (Arduini et al., 2012a).  Baker’s (2013) 
research investigated gas phase detection of OPCs and used AChE as the enzyme (Figure 
2).  As shown in Figure 2, AChE catalyzes the hydrolysis of acetylcholine (ACh) to 
produce acetic acid and choline.  If an OPC is present, the hydrolysis reaction is slowed 
due to permanent chemical bonding of the OPC onto the AChE active site.  Cyclic 
voltammeter (CV) measured the current response of the ACh hydrolysis reaction, as well 
as the extent of inhibition of the reaction due to OPC presence.  Thus, a biosensor based 
on the AChE/ACh hydrolysis reaction can be used to determine the presence of an OPC.  
BChE facilitates hydrolysis of butyrylthiocholine (BSCh) into butyrylic acid and 
thiocholine, much as AChE facilitates hydrolysis of ACh (Figure 3).  Baker (2013), who 
used acetylthiocholine (ASCh) in place of ACh as the substrate, demonstrated that 
inhibition of the current response of the AChE/ASCh reaction by a gas phase OPC, as 
measured by a CV, was proportional to the OPC concentration.   Like the AChE/ACh 
chemical reaction previously described, inhibition of the BChE/BSCh reaction in the 
5 
presence of an OPC can be directly measured with a cycle voltammeter (CV).  BChE 
transports OPCs from the pulmonary system to other locations within the body, such as 
to nerve cells where AChE is present (Evtugyn et al., 2013).  BChE demonstrates a 
different affinity to OPCs than AChE (Arduini et al., 2007; Arduini and Amine, 2014; 
Evtugyn et al., 2012). 
As part of a Cooperative Research and Development Agreement (CRADA) with 
the University of Toledo (UT) and Kwangwoon University, AFIT has been involved in 
the development of biosensors based on catalytic reaction and biomaterials (Baker, 2013; 
Stevens, 2012; Park, 2011; Park and Kim, 2012a; Park et al., 2010; 2011a; 2011b;  
2012b).  In the current study, Baker’s (2013) approach is closely followed.  However, 
BChE and BSCh were used instead of AChE and ASCh as the enzyme and substrate, 
respectively.  While Arduini’s earlier publications (2007 – 2013) and successes with 
BChE motivated this research, continued biosensor development utilizing BChE in lieu 
of AChE appears warranted to exploit BChE’s different chemical properties (Arduini & 
Amine, 2014).  In this research, a reusable SPE, see Figure 4, measured the electro-
chemical reactions depicted in Figure 3 (Andreescu et al., 2002; Andreescu and Marty, 
2006).  When the electro-chemical reaction in Figure 3 is exposed to OPCs, the reaction 
in step one is inhibited due to the lack of available BChE.  The intermediate breakdown 
of choline in step two produces hydrogen peroxide (Andreescu et al., 2006).  Hydrogen 
peroxide, through hydrolysis with HRP catalyst, is broken down into water.  HRP 
facilitates electron flow, allowing the reaction to take place at lower voltage (Park et al., 
2012b; Baker, 2013).  This lowers the electrical resistance between the anode and 
cathode and increases BChE/BSCh reaction rate sensitivity. 
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To protect enzyme function in biosensors, peptide nanotubes (PNTs) have been 
used (Park et al., 2010; 2012a; 2012b).  Protecting enzyme activity and stability increases 
shelf-life and performance of the biosensor.  As depicted in Figure 4, biosensor 
fabrication may include application of a final top layer component.  The top layer 
provides protection as well as assists with maintaining adhesion of the PNTs to the SPE.  
Nafion, a stable biocompatible Teflon based polymer, has been used to bind PNTs (and 
their associated enzymes) to an electrode (Baker, 2013).  When used in combination, 
PNTs, HRP, and Nafion are used to:  increase the contact area between the enzymes and 
chemical compounds, protect the enzymes, and increase sensor sensitivity. 
Problem Statement 
Because OPCs may cause harm at very low concentrations, sensitive and accurate 
sensors are necessary to protect military personnel and civilians (Goltz et al., 2011).  To 
meet demand for lower fiscal resource consumption, smaller, less expensive detectors 
need to be developed.  Such detectors could be worn by military service members, 
homeland security personnel, and industrial workers (e.g., civil engineering pest control 
personnel and chemical plant operators).  In addition, these small and sensitive 
biosensors can be integrated into a remote detection array or used on unmanned aerial 
vehicles to protect a central unit, building complex, or large population centers from 
distant, detectable threats. 
Two critical problems arise with enzyme-based biosensors: 1) enzyme 
deactivation over time, and 2) inadequate sensitivity to the target compound.  The UT 
and AFIT researchers are addressing these problems by 1) using Nafion and PNTs to 
protect the enzymes, thereby increasing the biosensor’s longevity, 2) using PNTs to 
facilitate contact between the enzymes and target compounds, and 3) using HRP to 
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facilitate electron flow, thereby enhancing  sensitivity (Stevens, 2012; Park et al., 2012b; 
Baker, 2013; Upadhyay and Verma, 2013). 
The objective of this research was to evaluate gas phase OPC biosensor detection 
based on electrochemical inhibition measurement of BChE facilitated BSCh hydrolysis.  
Section II is written in the Scholarly Article format.  Appendix A provides summary 
sensitivity and longevity information with an outline of methods used.  Appendices B and 
C provide chronological detail on the research experiments.  Appendix D provides the 
chemical materials ordering list.  This research explored small, reusable, and affordable 
BChE-based biosensors with low OPC gas concentration detection capability. 
Scope and Approach 
1. Encapsulate HRP in peptide nanotubes (PNTs) to effectively immobilize and 
protect the hydrolysis catalyst, then add butyrylcholinesterase (BChE) enzyme to the 
outside of the PNTs.  Finally, use Nafion to adhere the PNT/enzyme combination to a 
reusable gold screen printed electrode (see Figure 5).   
2. Use a cyclic voltammeter (CV) to obtain data that quantifies the inhibition 
response of the BChE/BSCh hydrolysis reaction to varying concentrations of a model 
OPC (e.g., malathion).  Determine: 
a. Sensitivity: determine the range over which the inhibition of the hydrolysis 
reaction is proportional to the concentration of the model OPC.  In addition, determine 
the detection limit for malathion.   
b. Longevity: for a given malathion concentration, determine how the inhibition 
response of the hydrolysis reaction to the presence of malathion is affected as a function 
of the time after sensor fabrication, when the sensor is stored at room conditions. 
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c. Reusability: assess the ability to utilize an SPE multiple times after an initial use, 
subsequent cleaning, and reapplication of new biosensor components to the SPE. 
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II. Scholarly Article 
Peptide Nanotube Encapsulated Enzyme for Vapor Phase Detection of 
Organophosphorus Compounds 
Christopher W. Edwards
a
, Mark N. Goltz
a
, Sushil Kanel
a
, Dong-Shik Kim
b
 
a 
Department of Systems Engineering and Management, Air Force Institute of Technology, WPAFB, OH 
45433 
b 
Department of Chemical & Environmental Engineering, University of Toledo, Toledo, OH 43606 
Abstract 
Previous studies demonstrated the potential application of a biosensor fabricated 
with an acetylcholinesterase (AChE) enzyme encapsulated in peptide-nanotubes (PNTs) 
and enhanced with horseradish peroxidase (HRP) to detect the presence of 
organophosphorus compounds (OPCs) in water and gas phases (Stevens, 2012; Baker, 
2013).  The biosensor was fabricated using a single-use screen printed electrode (SPE).  
In the current study, potential improvements to the biosensor are investigated.  The 
current study explores use of a butyrylcholinesterase (BChE) based biosensor using 
reusable SPEs that have a smaller working surface area than the single-use electrodes 
studied previously.   
BChE-based biosensors were fabricated using PNTs, HRP, and Nafion in 
combination to increase reactive surface area, enhance sensitivity, and maintain enzyme 
stability.  Cyclic voltammeter (CV) was used to measure gas phase concentration of the 
OPC malathion.  Results of this research showed that a BChE-based biosensor could 
reliably measure gas phase malathion concentrations between 6 and 25 ppbv by current 
inhibition, with the extent of inhibition linearly proportional to the malathion 
concentration.  The biosensors could be stored several weeks after fabrication at room 
temperature with minimal performance degradation.  The electrodes were each reused 
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several times, and still were useable at the conclusion of this study.  This research 
demonstrates the potential of fabricating a reusable, inexpensive biosensor capable of 
OPC detection with sensitivity and detection limit comparable to biosensors fabricated in 
previous studies.  
11 
Introduction 
Organophosphorus compounds (OPCs) include insecticides and warfare agents 
which irreversibly bind to acetylcholine esterase (AChE) receptors in the central nervous 
system.  OPCs prevent the nervous system from hydrolyzing acetylcholine (ACh), which 
consequently builds up.  ACh stimulates muscles, and when an OPC has irreversibly 
bound to AChE, ACh accumulates, resulting in continuous stimulation of muscle groups.  
When a vital muscle such as the diaphragm cannot relax, suffocation results and causes 
death within minutes (Boss et al., 2010).  Based upon the interaction of OPCs with 
AChE, previous studies have investigated use of esterase-based biosensors to detect 
OPCs in liquid (Park et al., 2011; Stevens, 2012) and gas (Baker, 2013) phases.  
Detection is based upon a redox reaction facilitated by the presence of AChE, using ACh 
or ASCh (acetylthiocholine) as substrates.  OPCs inhibit the reaction, and the 
concentration of the OPC can be determined by using a cyclic voltammeter to measure 
the extent of inhibition.  The AChE-based biosensor is fabricated on a gold screen printed 
electrode (SPE) using peptide nanotubes (PNTs), Nafion, and horseradish-peroxidase 
(HRP) in combination (see Figure 1) to increase reactive surface area, enhance 
sensitivity, and preserve enzyme stability over time (Arduini et al., 2007; 2013).  Baker 
(2013), who used acetylthiocholine (ASCh) as the substrate, demonstrated that inhibition 
of the current response of the AChE/ASCh reaction (see Figure 2) by a gas phase OPC 
was proportional to the OPC concentration.  Baker’s work was carried out on single use, 
disposable SPEs and closely paralleled a similar research effort by Arduini (2012b) who 
also developed a disposable electrochemical biosensor with a shelf-life of about fifty 
days.   
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Figure 1: Disposable Biosensor Construct (Baker, 2013) 
 
 
(Adapted from Baker, 2013) 
Figure 2: Normal Acetylcholine Hydrolysis and Inhibition of AChE by OP 
 
Screen Printed Electrode (SPE)  
- 4 mm diameter working surface area 
Base Level:  SPE 
Middle Layer:   
 1. External AChE 
 2. PNT w/HRP encapsulated 
Top Level:  Nafion 
Side View (Magnified) 
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Arduini et al. (2007) demonstrated cost effective application of a Prussian blue-
modified silver SPE using butyrylcholinesterase (BChE) enzyme and butyrylthiocholine 
(BSCh) as the substrate to detect the gas phase OPC nerve agents, Paraoxon, Sarin and 
VX.  In the current study, we investigate the potential of fabricating a BChE-based 
biosensor on a reusable gold-SPE, using PNT, HRP, and Nafion to increase stability and 
sensitivity.  The ability of the biosensor to measure malathion in the gas phase can then 
be evaluated.    
The principle upon which a BChE-based biosensor works is depicted in Figure 3 
(Andreescu et al., 2002; Andreescu and Marty, 2006).  BChE catalyzes hydrolysis of 
BSCh (Step 1).  The Step 1 reaction is inhibited by the presence of an OPC, because the 
OPC binds with the BChE enzyme.  The intermediate breakdown of thiocholine in step 
two produces hydrogen peroxide (Andreescu et al., 2006).  Hydrogen peroxide is  
 
(Adapted from Andreescu, 2006) 
Figure 3: BChE/BSCh enzyme electro-chemical reaction based biosensor 
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hydrolyzed in the presence of the HRP catalyst and is broken down into water.  Thus, 
addition of HRP on the sensor increases sensor sensitivity by facilitating electron flow 
and allowing the reaction to take place at lower voltages (Park et al., 2012b; Baker, 
2013). 
To enhance enzyme function in biosensors, peptide nanotubes (PNTs) have been 
used (Park et al., 2010; 2012a; 2012b).  The PNTs serve to protect enzyme activity, 
thereby increasing shelf-life and performance of the biosensor.  Biosensor fabrication 
may also include application of a final top layer component.  The top layer provides 
additional protection as well as acting as an adhesive to bind the PNTs to the electrode.  
Nafion, a Teflon-based stable polymer has been applied to bind PNTs (and their 
associated enzymes) to an electrode (Norouzi et al, 2010; Ren et al, 2012).  When used in 
combination, the three materials:  PNTs, HRP, and Nafion are used to: increase the 
contact area between the enzymes and the chemical compounds, protect the enzymes, and 
increase sensor sensitivity (See Figure 4). 
 
Figure 4:  Biosensor Construct 
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The goal of this line of research is to create an inexpensive BChE-based biosensor 
capable of OPC detection and explore its performance characteristics: longevity (post 
fabrication shelf-life under laboratory conditions), sensitivity (limit of detection (LOD), 
precision, OPC concentration-inhibition response relationship), and reusability of the SPE 
(using commercially available off the shelf (COTS) reusable SPEs).    
Materials, Equipment, and Methods 
Materials 
The B3128-1G, S-Butyrylthiocholine Chloride; C1057-1KU Butyrylcholinesterase 
From Equine Serum; P8250 – 5KU horseradish peroxidase (HRP); 180955-25G, Cellulose 
Acetate, 39.8 Wt. % Acetyl Content; 105228-25G, 1,1,1,3,3,3-Hexafluoro-2-Propanol, 
99+%; A1542-250G, Ammonium Acetate Molecular Biology Reagent; P3786-1KG, 
Potassium Phosphate Dibasic, ACS Reagent, >=98%, and Malathion >95% were purchased 
from Sigma Aldrich (St. Louis, MO).  ASCh and H-Phe-Phe-OH were purchased from 
Sigma Aldrich (St. Louis, MO), and stored at 4°C.  Nafion
©
 117 solution (approx. 5%) was 
purchased from Sigma Aldrich (Allentown, PA).  Deionized water was generated in the lab 
via reverse osmosis. 
Gold screen-printed electrodes (SPE), model RRPE2001AU-6, with a 2-mm-
diameter gold working electrode, the electrode-potentiostat interface cable, and the jacketed 
compact voltammetry cell were all purchased from Pine Research Instrumentation 
(Durham, NC).   
Equipment 
All electrochemical measurements were conducted using a Parstat 2273 Advanced 
Electrochemical System and PowerSuite ©Software from Princeton Applied Research.  
The SPE media were dried using AFIT supplied nitrogen gas.  Peptide nanotubes (PNTs) 
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were agitated using a Cole-Parmer 8890 Sonicator.  Experiments were completed using a 
Pine Research Instrumentation jacketed compact voltammetry cell.  Malathion 
concentration was determined using an Agilent Technologies 6890N Network GC Systems 
model gas chromatograph mass spectrometer (GC/MS) (Baker, 2013).   
Methods 
PNTs were synthesized by dissolving 100 mg of H-Phe-Phe-OH in one ml of 
1,1,1,3,3,3-hexafluoro-2-propanol.  This mixture was swirled gently by hand for a few 
seconds and then placed in a sonicator for five minutes to ensure complete dissolution.   
For some test configurations, to encapsulate the BChE inside the PNTs, one 
milliliter of PNT solution was dried overnight in a vacuum oven or ventilation hood with 
nitrogen gas applied.  One milliliter of 50 mM, 7.4 pH phosphate buffer solution (PBS) 
containing one milligram BChE was then added to the PNT solution.  Prior to selection and 
formal investigation into one compositional matrix, several fabrication processes were 
tried.  While some involved a simple change in the layering order, others involved the use 
of cellulose acetate and no protective Nafion covering.  Each compositional matrix was 
tested with the same protocol; qualitative performance criteria were used to select the 
compositional matrix with the highest prospects for continued research.  Ultimately, the 
primary test configuration chosen for this research involved PNT encapsulation of HRP 
utilizing the encapsulation process described above.  The PNT mixture was vortexed briefly 
and then incubated on a rotator in a temperature controlled environment at five Celsius, 30 
rpm for one week.  The PNT mixtures were kept refrigerated until needed for biosensor 
fabrication.   
As an initial test of a reusable electrode, a Pine Research SPE with one fourth the 
working surface area of the SPE used by Baker (2013) was purchased and utilized 
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throughout the following experiments.  The biosensors were prepared by first depositing 
2.5µL of PNTs containing the encapsulated BChE on the working electrode, which was 
then allowed to dry in a hood at room temperature and pressure (average of 65°F and 745 
mm Hg).  Then, 2.5µL of 1000 U/mL HRP was deposited on top of the PNTs and allowed 
to dry.  Next, 2.5µL of Nafion was deposited and allowed to dry.    
Vapor concentration for the sensitivity tests was adjusted by injecting a known 
volume of gas saturated at room temperature with malathion (vapor pressure = 25 ppbv), 
into a 40 ml vial purged with nitrogen at constant temperature.  The same set of SPEs was 
used for every subsequent sensitivity experiment.  After each sensitivity experiment at a 
specific malathion concentration, the SPEs were initially cleaned using methanol.  The CV 
instrument was utilized with the SPE immersed in a dilute acetic acid solution to further 
clean the SPE until the CV “finger print” plot demonstrated a baseline signature.  To 
evaluate SPE reusability, for each sensitivity experiment, the same SPEs were re-fabricated 
with new enzyme layering prior to exposure to a different malathion concentration.  The 
test protocol first involved electrode placement into a 20ml CV flask filled with a 7.4 pH 
PBS and CV measurement number one (CV#1) was taken.  CV#1 was used to verify the 
condition of the electrode prior to conducting the experiment.  After placement in the PBS 
solution, the CV#1 scan of the electrodes had a typical shape.  In the event the scan of an 
electrode was atypical, that electrode was not used until it was cleaned, refabricated, and 
CV#1 rerun.  After CV#1, the electrodes were then inserted into a 20ml CV flask 
containing one millimolar concentration BSCh, and CV measurement number two (CV#2) 
was taken.  The electrodes were then transferred to a 40 ml vial that had been purged with 
nitrogen and then injected with a fixed concentration of malathion gas vapor, and CV 
measurement number three (CV#3) was taken.  The characteristics of the CV#3 scan were 
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compared to earlier CV#3 scans to decide if subsequent test data from that electrode were 
valid.  Finally, the biosensor was reinserted into the BSCh containing vial to obtain a post 
malathion CV measurement four (CV#4).  In Figure 5, lines A and B represent pre-
malathion, CV#2, and post malathion, CV#4, respectively.    
Weekly longevity experiments involved simultaneous preparation of several sets of 
biosensors that were fabricated as described above and stored dry at room temperature (65 
degrees
 
Fahrenheit) in a dark cabinet.  At weekly intervals, one set of sensors underwent 
the same test protocol as described for the sensitivity experiment except the OPC 
concentration remained constant at 25 ppbv malathion in a 40ml vial when CV#3 was 
made.  
Results 
Analysis of CV signatures for the BChE-based biosensor are notably different 
between pre- and post malathion exposure (Figure 5, lines A and B).  The lines in figure 5 
are representative of a single biosensor electrode test.  Line A (CV#2) represents a single 
CV scan of the fabricated biosensor electrode prior to malathion exposure.  Line B (CV#4) 
represents a post malathion exposure scan.  Line C is the difference in current between line 
B and line A.   
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Figure 5: Representative CV Data for PNT w/HRP - BChE - Nafion Composition Matrix:  
Line A is CV#2 (Ipre), Line B is CV#4 (Ipost), and Line C is (Ipre - Ipost)  
As shown in Figure 5, this fabricated BChE-based biosensor example has a line C 
“finger print” region from -0.30 through -0.40 volts (indicated by the two vertical lines on 
the plot), where a distinctive peak for line C is realized.  For each sensitivity experiment a 
plot similar to Figure 5 was completed.  A visual inspection of the plot focused on Line C, 
looking for a characteristic peak within the -0.3 and -0.40 volts range.  This signature 
“finger print” peak on Line C indicated the biosensor was operating within normal 
parameters.  The line C peak (within the -0.30 to -0.40 voltage range) was used to calculate 
inhibition, as described below.   
For each biosensor tested, the percent inhibition was calculated using the following 
equation: 
Percent Inhibition =
(Ipre−Ipost)
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where:  Ipre and Ipost are current (A) values at a particular potential (V).  . 
As noted above, Line C is the numerator in Equation 1.  Thus, for each biosensor test, a 
peak in Line C was located within the potential range -0.3 and -0.4 volts and Equation 2 
applied: 
Percent Inhibition =
(Ipeak)line C
(Ipre)line A
 X 100 (2) 
where:  (Ipeak) is the current at the peak of line C (within the specified potential 
range) 
(Ipre) is the current value on line A determined from the same voltage input 
as Line C’s current peak output. 
Note that the CV scan lines in Figure 5 actually represent a smoothed fit to multiple 
data points.  To calculate an average percent inhibition from a particular CV scan, multiple 
pairs of data points along lines C and A (each pair of points corresponding to a particular 
voltage) were used in Equation (2) to calculate a percent inhibition at that voltage.  A 
minimum of three consecutive percent inhibition values were used to determine an average 
percent inhibition for each biosensor test.  Each data point shown in Figure 6 represents this 
average percent inhibition for a biosensor test.  Each data point shown in Figure 6 
represents the final percent inhibition value for a validated BChE-based biosensor electrode 
test. 
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Figure 6: Sensitivity Test Data: 
 
Note in Figure 6 that the linear correlation between percent inhibition and malathion 
concentration is relatively low.  Looking at the figure, the low correlation appears due to 
the measurements made of malathion concentrations less than 6 ppbv.  A new plot, Figure 
7, was created using data only from concentrations 6 ppbv and higher.  As seen in Figure 7, 
the linear correlation is markedly improved.  Thus, if we assume the limit of detection of 
the biosensor for malathion is 6 ppbv, we see that there is a linear relation between percent 
inhibition and malathion concentration for the range of concentrations between the LOD 
and the vapor pressure of malathion (25 ppbv).    
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Figure 7: Sensitivity Test Data:  
Simplified plot depicting only malathion concentrations above 6 ppbv; points represent 
average percent inhibition for multiple CV runs and “whiskers” represent the standard 
deviation. 
 
In Figure 8, biosensor current and percent inhibition is shown for the longevity 
experiment.  The longevity test data indicate that both biosensor current and percent 
inhibition should be considered when determining shelf life.  Noting that the current 
responses were minimal after week 6, another graph was plotted, Figure 9, using the first 
six weeks of data and including the 25 ppbv malathion concentration data point from 
Figure 7 to represent week zero.   
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Figure 8: BChE/BSCh Longevity Test Data Showing Inhibition Measured after Biosensor 
Exposure to 25 ppbv Malathion 
 
 
Figure 9: BChE/BSCh Longevity Test Data for First Six Weeks Showing Inhibition 
Measured after Biosensor Exposure to 25 ppbv Malathion 
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Discussion 
Regarding the sensitivity tests, OPC detection using a BChE-based biosensor is 
demonstrably improved when compared to Baker’s AChE-based biosensor.  At 6 ppbv, 
the LOD was lower than the LOD of 12 ppbv achieved with the AChE-based sensor, and 
the working surface area of the reusable electrode was one fourth the size of the 
disposable electrode used for the AChE studies.  While others have also investigated 
application of cholinesterase-based biosensors to detect gas phase nerve agents and other 
pesticides (e.g., Arduini et al., 2007; 2010; Arduini and Pelleschi, 2012b) those studies 
involved different compounds, and the results are not directly comparable to the results 
of this study.  However, the performance of the BChE-based malathion detector with a 
gas-phase LOD of 6 ppbv developed in this study provides evidence that such a detector 
may have potential applications for chemical warfare agent detection.     
For the longevity tests, Figure 8 shows a marked decrease in current after week 6 
for a biosensor stored at room temperature.  Baker (2013) demonstrated similar results, 
with an AChE-based biosensor’s performance degrading significantly between 45 days 
and 60 days after dry storage at 4 Celsius.  The results in the current study are also 
comparable to the results of fifty day longevity experiments conducted by Arduini et al. 
(2010) where different OPCs (VX, Sarin, and Paraoxon) were utilized.  
Conclusion 
This research demonstrated BChE/BSCh biosensors can be constructed to detect 
gas phase concentrations of malathion well below its vapor pressure of malathion.  Based 
on percent inhibition of the BSCh hydrolysis reaction, quantitative measurements can be 
made for malathion concentration between the LOD of 6 ppbv and the vapor pressure of 
25 
25 ppbv.   The sensors can be fabricated and stored at room temperature for up to six 
weeks with minimal performance degradation.    
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III. Conclusion 
Chapter Overview 
 
This chapter provides a synopsis of findings in relation to the original research 
goals outlined in Chapter 1.  However, due to length constraints for this manuscript, the 
scholarly article does not include some relevant discussion.  For additional details refer to 
Appendices A, B, and C.  This chapter also explores the limitations and the significance 
of this research, as well as provides suggestions for future research. 
Review of Findings 
 
The discussion below provides a review of the findings with regard to the research 
objectives presented in chapter one: 
1. Over what concentration range is the inhibition of the hydrolysis reaction 
proportional to the concentration of the model OPC, malathion?  What was the detection 
limit (LOD) for malathion? 
Inhibition of the BSCh hydrolysis reaction was found to be linearly proportional to 
malathion concentration between the vapor pressure of malathion (25 ppbv) and the LOD 
(6 ppbv). 
2. What was the post fabrication shelf-life for the BChE-based biosensor stored at room 
temperature?  
Based on experimental data, shelf-life, was about 6 weeks.  This compares with 
Baker’s (2013) AChE-based biosensor, which exhibited performance degradation after 45 
days after cold, dry storage at 4 Celsius. 
3. Could the SPEs used to construct the biosensor be reused?  Yes.  
27 
Significance of Research 
 
The ultimate goal of this research is to produce a working sensor that can be 
commercialized for OPC detection.  A small, wearable, simple detector could be used by 
agriculture workers to protect them from pesticide exposure or by soldiers who may be 
exposed to chemical warfare agents on the battlefield.  This research successfully 
demonstrated fabrication of an OPC biosensor that would reliably detect the presence of a 
model OPC at concentrations well below the OPC vapor pressure.  This research 
demonstrated that the biosensor could be stored after initial fabrication for up to six 
weeks without the need for refrigeration.   
Limitations 
 
OPC detection utilizing a BChE-based sensor involves reversibility with various 
compounds.  The reversibility of certain OPCs is variable based on the affinity of the 
exposure compound to BChE.  The affinity characteristic for each OPC lies along a 
spectrum of values.  In other words, while malathion was selected and used to develop 
this BChE-based sensor, other OPCs will have a different inhibition response.  Until this 
BChE-based biosensor is actually tested using more pesticides and warfare agents, 
extrapolating the data to other compounds is problematic.  Despite the encouraging 
success of this research, the inability to adequately extrapolate to more dangerous 
compounds is a definitive limitation of this research. 
Because the bond between malathion and BChE is reversible, data gathering 
proved challenging.  The percent inhibition measured in the CV test varied, depending on 
the time that elapsed between exposing the sensor to malathion and the CV measurement.  
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With two technicians working in tandem, it was possible to minimize this time and make 
more consistent measurements.  However, the standard deviation for the measurements in 
this research was compared to Baker’s (2013) AChE-based research and, it was 
demonstrably lower than this baseline.  As will be discussed in the next section, the 
BChE’s reversible binding property may be exploited for development of a reusable 
biosensor.   
Future Research 
 
Development of a reusable biosensor:   
Unlike Baker’s AChE-based biosensors which were disposable after a single use, a 
BChE-based biosensor may be reused after exposure to an OPC, due to the equilibrium 
seeking characteristic of the chemical process.  Due to the reversible nature of the BChE – 
malathion reaction, the ability to record inhibition between CV#2 and CV#4 during the 
experiment proved challenging.  A test protocol needs to be developed that can demonstrate 
consistency between successive malathion exposures to the same BChE biosensor without 
a re-fabrication of the SPE working surface area.   
/Confirm analysis:  BChE and AChE have comparable characteristics.  For 
true comparison the AChE-based biosensor needs to be conducted on the reusable 
electrodes.  Along with this, additional repeat studies on room temperature shelf-life 
should incorporate monitoring of both temperature and humidity variations.   
-based biosensor:  Unlike previous research which 
utilized disposable electrodes, this research successfully demonstrated electrode 
reusability.  While there is tremendous savings associated with reuse of gold plated 
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SPEs rather than single use, disposable SPEs, research and development is still 
costly.   
Recommendation:  Apply the methods in this study to investigate whether the inhibition 
response of a BChE-based biosensor will remain stable over multiple uses.   
 
Potential biosensor performance improvements: 
Based on the “no protective layer” test results carried out (Appendices B and C), 
sensors without Nafion utilizing BChE do require a protective layer such as Nafion or 
cellulose acetate.  The “no-Nafion” test affirmed that an additional protective layer such as 
Nafion has an important role in OP detection.  It was postulated that switching from Nafion 
to cellulose acetate, used as the protective layer over HRP-treated PNT-BChE modified 
electrode, would assist in immobilizing the enzyme on the PNTs and improve performance 
(Baker, 2013; Arduini & Palleschi, 2012b).  Arduini et al. (2012a) suggested using 
cellulose acetate instead of Nafion to further enhance biosensor performance.  Cellulose 
acetate may improve biosensor longevity.  Arduini and Amine (2014) have also indicated 
longevity, shelf-life success using a glutaraldeyde, bovine serum albumin (BSA), and 
Nafion biosensor composition matrix.  Instead of measuring longevity in weeks, Arduini 
and Amine (2014) expressed it in months while storing at room temperature and in dry 
conditions.  They indicated working stability is governed by pH, temperature, and matrix 
composition.   
Based on experimental testing, an inhibition measurement consistent with the 
literature review and previous AFIT research indicated that enhanced inhibition was 
likely, due to HRP and hydrolysis of hydrogen peroxide into water.  Significant biosensor 
longevity and sensitivity was achieved with chemically active HRP.  While fabricated 
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BChE biosensors have lasting performance without cold, dry storage; future research may 
be consistent with Baker’s 2013 AChE-based experiments.  Additional research effort 
may discover that refrigeration enhances BChE-based longevity.  Additional longevity 
testing with more robust environmental monitoring or further modification of the data 
gathering test procedure may be able to extend biosensor serviceable life and/or 
differentiate which environmental control variables will extend improved performance.  
The following is a list of some potential areas of future research: 
biosensor composition matrix (layering of PNT, catalyst, enzyme) and 
test sensor parameters:  Investigate the impact derived from keeping the enzyme 
fixed while changing the order of the fabrication layering process.  Room 
temperature, humidity, and compositional matrix may all impact biosensor 
sensitivity and longevity. 
ore biosensor development with alternative OPC detecting enzyme 
compounds:  Arduini and Amine (2014) noted several enzymes can be used in 
biosensor construction.  Among them are peroxidase, tyrosinase, laccase, and 
glucose oxidase.  From 2006 through 2012 research into these enzyme compounds 
has been limited.  Investigating the application of these enzymes for OPC detection 
appears warranted.   
It is evident that a small, reusable BChE-based electrode can be re-fabricated to detect 
low concentration gas phase malathion and subsequently utilized after several weeks in 
storage under standard laboratory conditions.  The next logical step beyond continued 
refinement of a reusable SPE is extending reusability of the actual fabricated biosensor.   
Recommendation:  Carry out additional research to further characterize and optimize the 
variables that extend longevity and reusability. 
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Appendix A.  Experiment Methodology 
A-1 Sensitivity Experiment: 
Vapor concentration was adjusted by injecting a known volume of gas saturated 
with malathion at its vapor pressure, a known concentration of 25 ppbv, into a 40 ml vial 
purged with nitrogen at constant temperature.  The resulting concentration was calculated 
after equilibration was achieved using Raoult’s law of thermodynamics.   
The biosensors were prepared by first depositing 2.5µL of PNT/HRP, which was 
then allowed to dry in a hood at room temperature and pressure (average of 65°F and 745 
mm Hg).  Then, 2.5µL of 1000U/mL BChE was deposited on top and allowed to dry.  
Finally, 2.5µL of protective Nafion was deposited and allowed to dry.  The biosensor was 
placed into a voltammeter flask filled with 7.4 pH phosphate buffer (PB) solution, and 
cyclic voltammetry (CV) measurements were taken.  The biosensors were removed from 
the PB solution and inserted into an identical vial with PB solution containing 1 mmol 
BSCh, and CV measurements were taken again.  The electrodes were then immediately 
transferred into a vial purged with nitrogen and replaced by a known concentration of 
malathion vapor.  Finally, the biosensor was reintroduced to the BSCh solution and a final 
CV test was administered.  The BSCh CV results from pre-malathion CV test and post 
malathion CV exposure test were compared.  Inhibition was calculated as the difference 
between measurements and the pre-malathion current at each recorded voltage 
measurement.   
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Table A-1: BChE/BSCh, Malathion Sensitivity Data 
 Percent Malathion Concentration – Sensitivity Summary Data 
Test Date 5 Sep 3 Oct 30 Sep 2 Oct 27 Sep 21 Oct 4 Oct 16 Oct 4 Oct 2 Oct 1 Oct 30 Sep 15 Oct 
Percent 100% 80% 75% 60% 50% 40% 25% 24% 20% 18.8% 10% 
(ppbv) 25 20 18.75 15 12.5 10 6.25 6
1
 5
2
 4.7
7
 2.5 
Electrode  
1 70.8
3
 - 44.2 36.8 33.5 37.6 55.0 36.3 15.9 - - - 45.9 
2 - 51.4 39.3 - 36.7 36.7 52.7 14.0 13.0 13.7
1
 - - 34.0 
3 - 42.6 33.3 41.3 50.6 33.8 56.1 29.6 12.5 - - - 40.6 
4 70.4 52.8 1.47
4
 44.8 40.5 29.3 48.3 21.9 12.4 - - - 28.7 
5 69.2 - 6.86
4
 -
5
 30.5 39.9 41.0
6
 20.8 -
5
 - 28.7 - 23.4 
6 68.3 - - - 55.8 24.9 21.8
6
 34.4 -
5
 21.6
1
 30.7 27.9
7
 12.6 
Average 69.3 48.9 38.9
8
 41.0
9
 41.3 33.7 45.8 26.1 13.4 17.6 29.7 - 30.9 
Std Dev 1.04 5.53 5.48
8
 3.99
9
 9.97 5.64 13.0 8.69 1.67 5.59 1.40 - 12.0 
Inhibition 
Summary 
67.6 44.6 37.2 40.3 40.3 33.5 45.1 25.8 12.4 - - - 31.1 
Potential 
(V) (max) 
-0.34 -0.49 -0.32 -0.33 -0.32 -0.32 -0.32 -0.32 -0.39 - - - -0.32 
Potential 
(V) (min) 
-0.34 -0.50 -0.33 -0.34 -0.34 -0.34 -0.33 -0.34 -0.41 - - - -0.33 
Note 1:  Exposure concentration standard was 6 ppbv:  25 ppbv*(16/40)*(24/40). 
Note 2:  Exposure concentration was 5 ppbv:  25 ppbv*(8/40), for these electrodes. 
Note 3:  Electrode 1 utilized a 40 ml malathion sample vial at 100% concentration, 25 ppbv, and was tested on 1 Oct. 
Note 4:  For the 75% malathion exposure electrodes 4 & 5 were excluded from summary data.  An error occurred during the 
process used to make the exposure 75% vial concentrations for electrodes 4 and 5.   
Note 5:  Results for this electrode were non-consistent and unusable. 
Note 6:  Electrode 5 utilized PNT/HRP formula that was 1 month old, electrode 6 utilized a formula that was 2 months old. 
Note 7:  Electrode 6 was prepared with a concentration of 4.7 ppbv malathion, 25ppbv *(16/40)*(30/40). 
Note 8:  Average calculation and standard deviation were calculated using electrodes 1, 2, and 3. 
Note 9:  Average calculation and standard deviation were calculated using electrodes 1, 3, and 4.  
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Table A-2: BChE/BSCh, Malathion Sensitivity Data (Continued) 
Percent Malathion Concentration – Sensitivity Pooled Standard Deviation Summary Data
1
 
Test Date 5 Sep 29 Oct 30 Sep 3 Nov 27 Sep 21 Oct 4 Oct 16 Oct 21 Oct 
Percent 100% 75% 50% 40% 
(ppbv) 25 18.75 12.5 10 
Electrode  
1 70.8
4
  44.2 52.0 33.5 37.6 55.0 36.3 34.3 
2   39.3 56.7 36.7 36.7 52.7 14.0 28.8 
3   33.3 58.1 50.6 33.8 56.1 29.6 40.0 
4 70.4 68.2  53.6 40.5 29.3 48.3 21.9 29.6 
5 69.2 65.7  53.9 30.5 39.9 41.0
6
 20.8 -
5
 
6 68.3 63.1  54.0 55.8 24.9 21.8
6
 34.4 40.7 
Average 69.3 65.7 39.0 54.7 41.3 33.7 45.8 26.1 34.7 
Std Dev 1.04 2.52 5.48 2.24 10.0 5.64 13.0 8.69 5.62 
Inhibition 
Summary 
67.6 65.5 37.2 54.4 40.3 33.5 45.1 25.8 34.5 
Potential 
(V) (max) 
-0.34 -0.32 -0.32 -0.33 -0.32 -0.32 -0.32 -0.32 -0.32 
Potential 
(V) (min) 
-0.34 -0.35 -0.33 -0.35 -0.34 -0.34 -0.33 -0.34 -0.34 
Pooled 
Average
2
 
68.0 49.5 37.5 35.6 
Pooled Std 
Dev
3
 
1.93 3.49 8.10 9.81 
Note 1:  Pooled standard deviation is the square root of pooled variance. 
Note 2:  Pooled Average is the average of all samples taken in each set divided by the number of samples. 
Note 3:  Pooled Standard Deviation = sqrt(Sp
2
) = sqrt{[(n1-1)s1
2
+(n2-1)s2
2
+ …(nk-1)sk
2
] / [n1+ n2+ … nk - k)]} 
Note 4:  Electrode 1 utilized a 40 ml malathion sample vial at 100% concentration, 25 ppbv, & was tested 1 Oct. 
Note 5:  Results for this electrode were non-consistent and unusable. 
Note 6:  Electrode 5 utilized PNT/HRP formula 1 month old, electrode 6 utilized a formula 2 months old. 
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A-2 Longevity Experiment: 
All biosensors were prepared as specified in Table 3 and allowed to age.  At one 
week intervals, the sensors were tested with 25 ppbv malathion vapor.  Longevity 
experiment results are described in Appendix C and summarized in the following tables. 
Table A-3. Longevity Exposure Experiment Preparation 
 
Biosensor Surface 
Preparation: 
Screen printed gold electrodes prepared with acetate solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to surface, dried using Nitrogen gas. 
Nafion protective top-cover applied. 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution.  CV #1 test 
applied.  Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution 
Applied CV #4 test.   
 
Table A-4: BChE/BSCh Biosensor Longevity Data 
 
Week 
0 1 2 3 4 5 6 8 10/11
3
 
Electrode Measured Inhibition (%) 
1  82.6 49.8 58.7 49.4 54.8 65.3 76.3 39.0 
2 - 72.4 62.1 67.8 44.3 54.0 65.0 82.5 55.3 
3 - 52.4 52.0 68.8 60.8 58.5 61.5 75.0 33.8 
4 70.4 54.0 50.2 78.1 42.1 66.7 65.0 82.5 3.98 
5 69.2 53.7 45.9 72.6 50.2 61.8 59.3 72.2 39.2 
6 68.3 50.7 61.9 66.3 51.6 60.9 38.6 72.7 51.0 
Average (%) 69.3 56.6 53.6 68.7 49.7 59.4 63.2 76.9 31.4 
Std Dev 1.04 8.90 6.78 6.48 6.54 4.75 2.72 4.60 8.41 
% Inhibition 
Summary 
67.6 53.0 50.9 68.2 49.2 59.0 58.4 76.1 31.2 
Potential (V) 
Range (max) 
-0.34 -0.34 -0.37 -0.34 -0.35 -0.35 -0.34 -0.32 -0.32 
Potential (V) 
Range (min) 
-0.34 -0.34 -0.38 -0.37 -0.37 -0.37 -0.35 -0.35 -0.34 
Note 1:  CV curve analysis during malathion exposure indicated the electrode surface was 
coated with liquid PB; this resulted in an a-typical inhibition response of the biosensor.   
Note 2:  Analysis of CV curve electrode data indicates the sensor surface may have been 
disrupted during the test protocol resulting in erroneous data.   
Note 3:  Linear trend analysis indicated dysfunctional malathion inhibition detection after 
week 6.  Biosensors 1, 2, and 3 were tested at week ten and electrodes 4, 5, and 6 were 
tested at week eleven. 
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Table A-5: BChE/BSCh Longevity Second Test with Pooled Standard Deviation  
Electrode 
Week
1
 
1 2 3 4 
1 -
4
 69.7 49.8 63.3 58.7 66.2 49.4 47.6 
2 72.4 64.7 62.1 32.2 67.8 61.7 44.3 43.2 
3 52.4 48.9 52.0 56.3 68.8 -
4
 60.8 37.6 
4 54.1 51.2 50.2 60.2 78.1 50.9 42.1 23.6 
5 53.7 59.2 45.9 63.3 72.6 55.4 50.2 58.2 
6 50.7 -
4
 61.9 53.0 66.3 56.8 51.6 57.3 
Average (%) 56.6 58.7 53.6 54.7 68.7 58.2 49.7 44.6 
Std Dev 8.90 8.78 6.78 11.7 6.48 5.89 6.54 13.0 
% Inhibition 
Summary 
53.0 58.0 50.9 53.8 68.2 58.2 49.2 44.4 
Potential (V) 
Range (max) 
-0.34 -0.33 -0.37 -0.34 -0.34 -0.32 -0.35 -0.32 
Potential (V) 
Range (min) 
-0.34 -0.36 -0.38 -0.36 -0.37 -0.35 -0.37 -0.35 
Pooled 
Average
2
 
57.7 54.2 63.9 47.2 
Pooled Std Dev
3
 8.84 9.58 6.22 10.31 
Note 1:  The 1st column of each week is from the 1st longevity data set; the second is from a 4 
week 2nd run. 
Note 2:  Pooled Average is the average of all samples taken in each set divided by the number 
of samples. 
Note 3:  Pooled Standard Deviation = √(Sp
2
) = √{[(n1-1)s1
2
+(n2-1)s2
2
+ …(nk-1)sk
2
] / [n1+ n2+ … 
nk - k)]} 
Note 4:  CV curve was non-consistent and unusable. 
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Appendix B.  Air Force Institute of Technology Thesis Results 
B-1 Initial Experiment: 
On 24 Jun 13, after receiving the initial chemical purchase order to conduct the 
thesis project, the first question that needed to be answered was whether the newly 
purchased Pine Research gold electrodes would achieve results similar to previous work 
using electrodes from another manufacturer.  The newly purchased electrodes from Pine 
Research have a working surface area diameter one half the size.  This reduced the surface 
area to one quarter the size previously used.  The second question was whether switching 
BChE in lieu of AChE while still using the gas phase detection laboratory protocol 
developed by Peter Baker would still work.   
As a test, two electrodes were prepared with 2.5 µL of PNTs encapsulating HRP.  
One electrode had 2.5 µL AChE applied to the working electrode surface.  The other had 
2.5 µL of BChE applied to the surface and allowed to dry.  The electrodes were then coated 
with Nafion, allowed to dry, and then were tested.  See Table B-1 for a synopsis of the 
biosensor development and test protocol.   
Table B-1:  AChE vs. BChE Using Reusable Electrodes 
 
 
Surface 
Preparation: 
Two electrodes cleaned with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
AChE mid-layer added to electrode. 
BChE mid-layer added to electrode. 
Nafion protective top-cover applied. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Biosensor Test: Immersed in BSCh or ASCh solution and CV #2 applied. 
The electrode was immersed in PBS and a cyclic voltammeter test, CV#1, was 
taken.  Then the electrode was removed from the solution and immersed in a PBS with one 
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millimolar BSCh or 1mmol ASCh solution and a CV was again taken.  The CV “Finger 
print” for each electrode along with the difference is plotted in Figure B-1.   
As expected, analysis of the CV signatures for BChE and AChE are notably 
different.  To better understand the difference, a third line was developed that subtracted 
the ATCh result from the BSCh line.  Finally, the “Difference” calculation was divided by 
the original corresponding BSCh data points to produce a standardized ratio.  From this, 
two distinctive regions of potential interest were noticed.  BChE was a distinctive CV 
fingerprint region at 0.7 – 0.5 Volts and another at -0.3 – -0.5 Volts setting it apart from 
AChE. 
 
Figure B-1:  Initial BChE and AChE Comparison Test 
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B-2 Establishing Baseline Experiment:  (Repeating Peter Baker’s Thesis Work) 
On 8 Jul, six electrodes were prepared with 2.5 µL of PNTs encapsulating HRP.  
All six electrodes had 2.5 µL AChE applied to the working electrode surface and allowed 
to dry.  The electrodes were coated with Nafion, allowed to dry, and then were tested.  See 
Table B-2 for a synopsis of the biosensor development and test protocol.  The electrode 
was immersed in PBS and a cyclic voltammeter test, CV#1, was taken.  Afterward, the 
electrode was removed from the solution and immersed in a PBS with one millimolar 
ASCh solution and a CV was again taken.  The electrode was inserted into a gaseous 
environment for two minutes of exposure containing 25 ppbv malathion gas and another 
cyclic voltammogram was taken.  Finally, the electrode was reintroduced to the ASCh 
solution and another CV test was administered. 
Table B-2:  AChE Using Reusable Electrode Biosensor Preparation: 
 
Surface 
Preparation: 
Six electrodes cleaned with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
AChE mid-layer added to three electrodes. 
Nafion protective top-cover applied. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in ATCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into ASCh solution 
Applied CV #4 test.   
 
Analysis of the CV signatures for ATCh are notably different between pre- and post 
malathion exposure.  To better understand the difference, a third line was developed and 
plotted in Figure B-2 that subtracted the ATCh pre-malathion exposure from the post 
malathion exposure.  Finally, the “Difference” calculation was divided by the original 
corresponding ATCh data points to produce a standardized ratio.  From this, two distinctive 
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regions of potential interest were noticed.  AChE was a distinctive CV fingerprint region at 
about 0.57 – 0.35 volts and another at -0.32 - -0.45 volts.  After reviewing the areas of 
potential interest in Figure B-2, Table B-3 records the percentage of malathion inhibition 
measured on the right side “Area of Potential Interest” since it demonstrates a higher peak.  
Individual sensor and summary information was recorded. 
 
Figure B-2:  Initial AChE and ATCh Biosensor Test 
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Table B-3:  AChE Using Reusable Electrodes 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.35 86.26 
2 -0.32 through -0.36 89.57 
3 -0.37 through -0.38 89.33 
4 -0.39 through -0.41 75.95 
5 -0.42 through -0.45 73.69 
6 -0.42 through -0.44 69.41 
Result Average -0.36 through -0.39 76.22 
Std Dev  7.59 
 
B-3 Establishing BSCE – Cellulose Acetate Baseline:   
On 22 Jul, six electrodes were prepared with 2.5 µL of PNTs encapsulating HRP.  
All six electrodes had 2.5 µL BChE applied to the working electrode surface and allowed 
to dry.  The electrodes were coated with cellulose acetate, allowed to dry, and then were 
tested.  See Table B-4 for a synopsis of the biosensor development and test protocol.  The 
electrode was immersed in PBS and a cyclic voltammeter, CV#1, was taken.  Afterward, 
the electrode was removed from the solution and immersed in a PBS with one millimolar 
BChE solution and a CV was again taken.  The electrode was inserted into a gaseous 
environment for two minutes of exposure containing 25 ppbv malathion gas and another 
cyclic voltammogram was taken.  Finally, the electrode was reintroduced to the BSCh 
solution and another CV test was administered. 
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Table B-4:  BChE Using Reusable Electrode Biosensor Preparation: 
 
Surface 
Preparation: 
Six electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
Cellulose acetate dissolved in acetone applied as top-cover. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in ATCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into ATCh solution 
Applied CV #4 test.   
Analysis of the CV signatures for BSCh are notably different between pre- and post 
malathion exposure.  To better understand the difference, a third line was developed and 
plotted in Figure A-3 that subtracted the BSCh pre-malathion exposure from the post 
malathion exposure.  Finally, the “Difference” calculation was divided by the original 
corresponding BChE data points to produce a standardized ratio.  From this, one distinctive 
regions of potential interest was noticed.  BChE with cellulose acetate has a distinctive CV 
fingerprint region at about -0.30 - -0.45 volts.  After reviewing the area of potential interest 
in Figure B-3, Table B-5 records the percentage of malathion inhibition measured.  Both 
individual electrode information as well as the summary curve was recorded. 
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Figure B-3:  Initial BChE and BSCh Biosensor Test w/Cellulose Acetate 
Table B-5:  BChE Inhibition Peak Using Reusable Electrodes 
Electrode # Potential (V) Inhibition (%) 
1 -0.33 through -0.35 82.71 
2 -0.32 through -0.35 65.27 
3 -0.32 through -0.34 72.79 
4 -0.33 through -0.36 84.62 
5 -0.33 through -0.37 56.18 
6 -0.35 through -0.36 65.53 
Result Average -0.33 through -0.35 70.56 
Std Dev  11.93 
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B-4 Establishing BSCE – Nafion Baseline through Experimentation:   
On 8 Aug, two electrodes were prepared with 2.5 µL of PNTs encapsulating HRP.  
Both electrodes had 2.5 µL BChE applied to the working electrode surface and allowed to 
dry.  The electrodes were top coated with Nafion and then were tested.  See Table B-6 for a 
synopsis of the biosensor development and test protocol.  The electrode was immersed in 
PBS and a cyclic voltammeter, CV#1, was taken.  Afterward, the electrode was removed 
from the PBS and immersed in a PBS with one millimolar BChE solution and a CV was 
again taken.  The electrode was inserted into a gaseous environment for two minutes of 
exposure containing 25 ppbv malathion gas and another cyclic voltammogram was taken.  
Finally, the electrode was reintroduced to the BSCh solution and another CV test was 
administered. 
Table B-6:  BChE Using Reusable Electrode Biosensor Preparation: 
 
Surface Preparation: 
Two electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
Nafion dissolved in DI water applied as top-cover. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase Exposure: Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh are notably different between pre- and post 
malathion exposure.  A third line was plotted in Figure A-4 that subtracted the BSCh pre-
malathion exposure from the post malathion exposure.  The “Difference” calculation was 
divided by a constant value to produce a standardized ratio which was plotted on the 
secondary axis.  From this, one area of potential interest was noted.  BChE with Nafion has 
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a distinctive CV “finger print” region at about -0.30 through -0.40 volts.  After reviewing 
the area of potential interest in Figure B-4, Table B-7 records the percentage of malathion 
inhibition measured.  Both individual electrode information as well as the summary curve 
were recorded.  No voltage potential peak at 0.45V was observed. 
 
Figure B-4:  Initial BChE and BSCh Biosensor Test with Nafion 
Table B-7:  BChE Inhibition Peak Using Reusable Electrodes 
Electrode # Potential (V) Inhibition (%) 
5 -0.32 through -0.35 63.08 
6 -0.33 through -0.34 57.90 
Result Average -0.32 through -0.34 60.28 
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B-5 PNT – HRP - BSCE – Nafion Covered Biosensor Layering Variations:   
On 16 Aug, six electrodes were tested after preparing them in three different 
layering configurations.  Two electrodes were prepared with 2.5 µL of PNTs encapsulating 
HRP as the first layer followed by BChE and Nafion like the electrodes prepared on 8 Aug.  
The middle two electrodes were prepared using PNTs with no HRP encapsulation with 
BChE and Nafion.  The last two electrodes were prepared with PNTs encapsulating BChE, 
HRP was added as the middle layer followed by the Nafion.  See Figure B-5 for additional 
clarification.  See Table B-8 for a synopsis of the biosensor development and test protocol.   
 
Figure B-5:  Initial Layering Configuration with Nafion 
Table B-8:  BChE Using Reusable Electrode Biosensor Preparation: 
 
Surface 
Preparation: 
Six electrodes prepared in groups of 2 according to Fig. B-5.  
Nafion dissolved in DI water applied as top-cover. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh are notably different between pre- and post 
malathion exposure.  A third line was plotted in Figure B-6 that subtracted the BSCh pre-
malathion exposure from the post malathion exposure.  The “Difference” calculation was 
 External BChE 
 External HRP 
   PNT w/o HRP  
       
     PNT w/BChE 
        
SPE 5 & 6 SPE 3 & 4 
Top Level Nafion 
SPE 1 & 2 
BChE mid-layer 
PNTs w/no HRP PNTs w/BChE 
HRP mid-layer BChE mid-layer 
PNTs w/HRP 
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divided by a constant value to produce a standardized ratio which was plotted on the 
secondary axis.  From this, one area of potential interest was noted.  BChE with Nafion has 
a distinctive CV “finger print” region at about -0.30 through -0.40 volts.  After reviewing 
the area of potential interest for electrodes 1 & 2 in Figure B-6, Table B-9 records the 
percentage of malathion inhibition measured.  Similarly, Figure B-7 and Figure B-8 display 
results for electrodes 3 & 4 and 5 & 6, respectively.  Table B-10 provides summary 
information for four electrodes, 3 through 6. 
  
Figure B-6:  PNT – HRP, BChE and Nafion Test 
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Table B-9:  BChE Inhibition Peak Using Screen Printed Electrode 
Test Configuration One 
Electrode # Potential (V) Inhibition (%) 
1 -0.30 through -0.31 39.41 
2 -0.31 through -0.34 41.11 
Result Average -0.30 through -0.32 40.18 
 
 
 
Figure B-7:  PNT without HRP, BChE, and Nafion Test 
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Figure B-8:  PNT with BSCE, HRP, and Nafion Test 
Table B-10:  BChE without HRP and BChE Encapsulation  Summary 
Test Configuration Two 
Electrode # Potential (V) Inhibition (%) 
3 -0.29 through -0.30 39.44 
4 -0.30 through -0.34 51.51 
Result Average -0.30 through -0.34 45.28 
Test Configuration Three 
Electrode # Potential (V) Inhibition (%) 
5 -0.33 through -0.34 39.41 
6 -0.34 through -0.35 57.18 
Result Average -0.34 50.95 
 
In order to better illustrate and compare the standardized CV curves in Figures B-6 
through B-8 another graph was developed with all three onto Figure B-9.  Based on this 
information, the recipe formulation with the greatest Inhibition demonstration was PNT 
with BSCE encapsulated followed by HRP application and Nafion added as a protective 
cover. 
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Figure B-9:  Comparison of Three Sensor Formulas 
B-6 PNT w/HRP Experiment: 
An initial experiment performed on 16 Aug 13, failed to produce results consistent 
with the literature review.  Specifically, the PNT encapsulation of HRP failed to enhance 
the CV curve and the corresponding expected measurement of chemical detection through 
inhibition.  Upon review, the 16 Aug TCO formula utilized a PNT w/HRP solution nearly 
two months old.  If the HRP was no longer chemically active, this would explain the 16 
Aug TCO results.  To test this hypothesis, a new batch of PNTs w/HRP was created to 
retest the 16 Aug TCO.  See Section B-6, Verifying 16 Aug Test Configuration One (TCO) 
Test Result, for more details.  Retesting the 16 Aug TCO on 9 Sep resulted in a different 
CV response curve.  For malathion detection, HRP has a significant, enhancing impact.  
Based on the 9 Sep TCO validation test, the 16 Aug TCO data is rejected due to apparent 
chemical inactivity of the HRP solution. 
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Verifying 16 Aug Test Configuration One (TCO) Test Result:   
On 5 Sep and 29 Oct, three electrodes were prepared with 2.5 µL of PNTs 
encapsulating HRP.  All three electrodes had 2.5 µL BChE applied to the working 
electrode surface and allowed to dry.  The electrodes were coated with Nafion, allowed to 
dry, and then were tested.  See Table B-11 for a synopsis of the biosensor development and 
test protocol.  The electrode was immersed in PBS and a cyclic voltammeter, CV#1, was 
taken.  Afterward, the electrode was removed from the solution and immersed in a PBS 
with one millimolar BChE solution and a CV was again taken.  The electrode was inserted 
into a gaseous environment for two minutes of exposure containing 25 ppbv malathion gas 
and another cyclic voltammogram was taken.  Finally, the electrode was reintroduced to the 
BSCh solution and another CV test was administered. 
Table B-11:  BChE - Reusable Biosensor Preparation: 
 
Surface 
Preparation: 
Six electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
Nafion dissolved in DI water applied as top-cover. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in ATCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into ATCh solution 
Applied CV #4 test.   
Analysis of the CV signatures for BSCh are notably different between pre- and post 
malathion exposure.  To better understand the difference, a third line was developed and 
plotted in Figure B-10 that subtracted the BSCh pre-malathion exposure from the post 
malathion exposure.  Finally, the “Difference” calculation was divided by the original 
corresponding BChE data points to produce a standardized ratio.  From this, the distinctive 
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region of potential interest was again noticed.  BChE with Nafion has a distinctive CV 
fingerprint region at about -0.30 through -0.40 volts.  After reviewing the area of potential 
interest, Table B-12 & B-13 records the percentage of malathion inhibition measured on 5 
Sep and 29 Oct, respectively.  Both individual electrode information as well as the 
summary curve was recorded. 
 
Figure B-10:  PNT w/HRP - BChE/BSCh Nafion Biosensor Re-Test (5 Sep)  
  
-30
-20
-10
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
-0.0002
-0.00018
-0.00016
-0.00014
-0.00012
-0.0001
-0.00008
-0.00006
-0.00004
-0.00002
0
0.00002
0.00004
0.00006
-0.8-0.7-0.6-0.5-0.4-0.3-0.2-0.100.10.20.30.40.50.60.70.80.91
St
an
d
ar
d
iz
e
d
 R
at
io
: (
D
if
f 
(C
u
rr
e
n
t(
A
) 
)/
 (
1
.1
0
7
E
-0
6
)
C
u
rr
e
n
t 
(A
)
Potential (V)
PNT w/HRP - BChE - Nafion - Pre- & Post Malathion
Average Pre-Malathion
Average Post Malathion Exposure
Diff (Pre- Minus Post) Malathion
9 Sep, Biosensor Re-Test - (PNT w/HRP, BSCE, & Nafion)
Previous 16 Aug, SPE TCO Formula (PNT w/HRP, BSCE, Nafion)
Area of Interest 
 
52 
 
Table B-12:  BChE Inhibition Peak Using PNT w/HRP & Nafion - 5 Sep 
Electrode # Potential (V) Inhibition (%) 
4 -0.34 through -0.36 70.37 
5 -0.33 through -0.34 69.18 
6 -0.34 through -0.34 68.29 
Peak Average 
Std Dev 
 
 
69.28 
1.04 
Result Average -0.34 through -0.34 67.58 
 
Table B-13:  BChE Inhibition Peak Using PNT w/HRP & Nafion – 29 Oct 
Electrode # Potential (V) Inhibition (%) 
4 -0.32 through -0.35 68.16 
5 -0.32 through -0.35 65.74 
6 -0.35 through -0.36 63.13 
Peak Average 
Std Dev 
 
 
65.68 
2.52 
Result Average -0.32 through -0.35 65.48 
 
B-7 Conducting Electrode Experiment Without Nafion: 
One set of electrodes was prepared with 2.5 µL of PNTs encapsulating HRP.  Just 
prior to testing, 2.5 µL of BChE was added on top of the PNTs.  Once dry, the electrode 
was immersed in PBS and a CV was taken.  Then the electrode was removed from the 
solution and immersed in a PBS with one millimolar BSCh and CV#2 was again taken.  
The electrode was inserted into a gaseous environment containing malathion gas for two 
minutes and CV#3 was applied.  Finally, the electrode was re-inserted into the BSCh 
solution to measure the post malathion inhibition.  The experiment protocol is summarized 
in the following table.  
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Table B-14:  Sensor Experiment without Nafion Protective Cover: 
 
Surface 
Preparation: 
Six electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution. 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh is notably different when Nafion is absent.  
To better understand the difference, a third line was developed and plotted in Figure B-11 
that subtracted the BSCh pre-malathion exposure from the post malathion exposure.  
Finally, the “Difference” calculation was divided by the original corresponding BChE data 
points to produce a standardized ratio.  From this, the distinctive region of potential interest 
was again noticed.  BChE without Nafion has a distinctive CV fingerprint region at about -
0.30 - -0.40 volts.  After reviewing the area of potential interest, Table B-15 records the 
percentage of malathion inhibition measured.  Both individual electrode information as 
well as the summary curve was recorded. 
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Figure B-11:  BChE/BSCh Biosensor without Nafion 
Table B-15:  BChE Inhibition Peak Using PNT w/HRP & Nafion 
Electrode # Potential (V) Inhibition (%) 
1 -0.39 through -0.40 52.61 
2 -0.39 through -0.42 32.39 
3 -0.40 through -0.41 38.04 
4 -0.42 through -0.43 26.43 
5 -0.42 through -0.43 20.67 
6
1
 -0.46
1
 4.06
1
 
Average 
Std Dev 
 34.03 
12.25 
Result Average -0.42 through -0.43 27.09 
Note 1:  Results from this electrode were non-consistent and 
unusable. 
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B-8 Sensitivity Experiment With Fifty Percent Concentration – 12.5 ppbv: 
On 27 Sep 13, a set of electrodes was prepared according to Table B-16 for the 
purpose of determining the biosensor sensitivity.  Six 40ml vials were also prepared the 
previous day using 20 ml of malathion vapor gas at 25 ppbv combined with 20 ml nitrogen 
gas using a laboratory method developed by Peter Baker in his research.   
Table B-16:  Sensor Experiment with Malathion at 12.5 ppbv: 
 
Surface 
Preparation: 
Six electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution. 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh indicates lower detection through 
inhibition.  To better understand the difference, a third line was developed and plotted in 
Figure B-12 that subtracted the BSCh pre-malathion exposure from the post malathion 
exposure.  Finally, the “Difference” calculation was divided by the original corresponding 
BChE data points to produce a standardized ratio.  From this, the distinctive region of 
potential interest was again noticed.  BChE detection at fifty percent concentration has a 
distinctive CV fingerprint region at about -0.30 through -0.40 volts.  After reviewing the 
area of potential interest, Table B-17 records the percentage of malathion inhibition 
measured.  Both individual electrode information as well as the summary curve was 
recorded. 
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Figure B-12:  BChE/BSCh Biosensor with Fifty Percent Malathion 
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Table B-17:  BChE Inhibition Peak with Fifty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.33 through -0.34 33.46 
2 -0.32 through -0.34 36.72 
3 -0.31 through -0.32 50.63 
4 -0.33 through -0.35 40.50 
5 -0.34 through -0.36 30.47 
6 -0.35 through -0.36 55.79 
Peak Average 
Std Dev 
 
 
41.26 
9.97 
Result Average -0.32 through -0.34 40.27 
 
Testing the BChE sensor with fifty percent malathion exposure produces a 
diminished characteristic peak in the potential area of interest.  Experimental results for the 
peak amount of Inhibition is more variable; based on previous data, BChE biosensors can 
detect malathion at 12.5 ppbv.  The 27 Sep exposure test affirms that with the right quality 
control and experimental set up malathion can be sensed at 12.5 ppbv. 
 
B-9 Sensitivity Experiments with Sixty, Seventy-five, and Eighty Percent Concentration: 
On 2 Oct, 30 Sep, and 3 Oct 13 a set of electrodes was prepared according to Table 
B-18 for the purpose of determining the sensitivity at sixty, seventy-five and eighty percent 
concentration, respectively.  Six 40 ml vials were prepared the day prior day using 
malathion vapor gas at 25 ppbv combined with nitrogen gas to achieve the appropriate gas 
vapor concentration.   
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Table B-18:  Experiments with Malathion at Varied Concentration: 
 
Surface 
Preparation: 
Six electrodes prepared with acetate cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution. 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh indicates inhibition.  To better understand 
malathion interaction, a third line was developed and plotted in Figure B-13, B-14, and 
B-15 showing the difference between the BSCh pre-malathion exposure and the post 
malathion exposure for the varied concentrations.  From this, the region of potential interest 
was noticed.  BChE detection at seventy-five percent concentration has a distinctive CV 
fingerprint region at about -0.30 through -0.40 volts.  During the 75% malathion exposure 
experiment, electrodes four and five appeared to show almost no CV inhibition response 
curve and was likely due to no malathion exposure.  See figures B-16 and B-17 for 
additional detail.  Review of the method used to make the 75% malathion concentration for 
electrode 6 indicated it had less than 5 ppbv malathion.  The malathion vials for electrodes 
4 through 6 appear to have had less than 18.75 ppbv malathion concentration.  For the 
seventy five percent concentration experiment, electrodes 4 through 6 were excluded from 
the summary data.  Tables B-19, B-20, and B-21 summarize the malathion inhibition. 
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Figure B-13:  BChE/BSCh Biosensor with Seventy Five Percent Malathion Exposure 
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Table B-19:  BChE Inhibition Peak with 75% Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.33 44.22 
2 -0.34 through -0.35 39.32 
3 -0.31 through -0.32 33.28 
4 -0.33 through -0.35 -1.47
1
 
5 -0.32 through -0.35 6.86
1
 
6 -0.32 through -0.34 27.87
2
 
Peak Average 
Std Dev 
 
 
38.94
3
 
5.48
3
 
Result Average -0.33 through -0.33 37.16
3
 
Note 1:  Electrodes 4 and 5 indicate non-consistent CV response, 
inhibition unusable.     
Note 2:  The gas phase concentration preparation process, electrode 6 was 
exposed to 4.69 ppbv malathion.  (25ppbv*(0.25) * (0.75)) = 
4.69 ppbv. 
Note 3:  Peak Average, Standard Deviation, and Result Average are based 
on electrodes 1 through 3 data. 
 
 
 
Figure B-14:  BChE/BSCh Biosensor with Sixty Percent Malathion Exposure 
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Table B-20:  BChE Inhibition Peak with Sixty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.31 through -0.33 36.80 
2 -0.32 through -0.34 13.68
1
 
3 -0.32 through -0.33 41.34 
4 -0.33 through -0.35 44.75 
5 - -
2
 
6 -0.32 through -0.34 21.59
1
 
Peak Average 
Std Dev 
 
 
40.96 
3.99 
Result Average -0.33 through -0.34 40.30 
Note 1:  Exposure concentration standard for electrode 2 and 6 was 
six ppbv; calculated during preparation as {25 ppbv * 
(16/40) * (24/40)} 
Note 2:  CV curve results for electrode 5 were non-consistent and 
unusable. 
Electrodes 2, 5 and 6 were excluded from 60% malathion summary 
data. 
 
 
 
Figure B-15:  BChE/BSCh Biosensor with Eighty Percent Malathion Exposure  
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Table B-21:  BChE Inhibition Peak with 80% Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.35 through -0.36 70.78
1
 
2 -0.49 through -0.50 51.42 
3 -0.49 through -0.49 42.60 
4 -0.38 through -0.39 52.79 
5 -0.36 through -0.37 28.74
2
 
6 -0.31 through -0.32 30.72
2
 
Peak Average 
Std Dev 
 
 
48.94
3
 
5.53
3
 
Result Average -0.49 through -0.50 44.57 
Note 1:  Electrode 1 used a malathion sample at 100% concentration, 
25 ppbv.   
Note 2:  Electrode 5 and 6 were run with vials containing 5 ppbv 
malathion concentration, 25ppbv * (8/40) = 5 ppbv. 
Note 3:  Electrodes 1, 5, and 6 were excluded from summary data 
calculations. 
Testing the BChE sensor with sixty, seventy five, and eighty percent malathion 
exposure produces a consistent, diminished characteristic peak in the potential area of 
interest.  These multiple exposure tests affirm malathion inhibition can be measured at 20, 
18.75 and 15 ppbv. 
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Figure B-16: CV Curve Indicating Minimal Inhibition during Experiment 
 
Figure B-17:  CV Curve Indicating No Inhibition during Experiment 
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B-10 Sensitivity Experiments with Forty and Twenty Five Percent Concentration: 
On 4 Oct, two sets of electrodes was prepared according to Table B-22 for the 
purpose of determining the sensitivity at forty and twenty five percent concentration, 
respectively.  Twelve 40ml vials were prepared the day prior day using malathion vapor 
gas at 25 ppbv combined with nitrogen gas to achieve the appropriate gas vapor 
concentration for each experiment.   
Table B-22:  Experiments with Malathion at Varied Concentration: 
 
Surface 
Preparation: 
Six electrodes prepared with cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution. 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh indicate inhibition.  To better understand 
malathion interaction, refer to Figure B-18 and B-19 showing the difference between the 
BSCh pre-malathion exposure and the post malathion exposure.  The area of interest is 
highlighted.  BChE detection at forty percent concentration has a distinctive CV fingerprint 
region at about -0.30 through -0.40 volts.  During SPE preparation, a new cleaning agent, 
potassium bromide, was utilized on SPEs two through six.  During the twenty five percent 
malathion exposure experiment, electrodes two, three, and four indicated a right shifted 
Potential (V) peak; it was likely due to potassium bromide, KBr, cleaning agent residual.  
See Figures B-19 through B-21 for additional detail.  For the twenty five percent 
concentration experiment, SPEs 5 and 6 were excluded from the summary data.  Tables 
B-23 and B-24 summarize the malathion inhibition. 
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Figure B-18:  BChE/BSCh Biosensor with Twenty-Five Percent Malathion 
Table B-23:  BChE Inhibition Peak with 25% Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.33 through -0.37 15.91 
2 -0.46 through -0.47 12.95
1
 
3 -0.45 through -0.46 12.45
1
 
4 -0.44 through -0.46 12.40
1
 
5 -
2
 -
2
 
6 -
2
 -
2
 
Peak Average 
Std Dev 
 
 
13.43
3
 
1.67
3
 
Result 
Average 
-0.39 through -0.41 12.35
3
 
Note 1:  During the electrode preparation process, electrodes 2, 3, and 4 
were cleaned using a 1mmol potassium bromide solution in lieu of 
acetic acid.  Although the CV response curves were stable, the 
Potential (V) peak was right shifted. 
Note 2:  CV response curves for electrodes 5 and 6 were not stable and 
indicated no inhibition response. 
Note 3:  Peak Average, Standard Deviation, and Result Average are 
calculated using SPE 1, 2,3 and 4 data. 
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Figure B-19:  BChE/BSCh Biosensor with Forty Percent Malathion Exposure 
Table B-24:  BChE Inhibition Peak with Forty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.33 54.99 
2 -0.32 through -0.33 52.71 
3 -0.33 through -0.34 56.13 
4 -0.34 through -0.35 48.30 
5 -0.34 through -0.35 40.96
1
 
6 -0.33 through -0.34 21.84
2
 
Peak Average 
Std Dev 
 
 
45.82
3
 
12.98
3
 
Result Average -0.33 through -0.34 45.09
3
 
Note 1:  SPE 5 utilized PNT/HRP solution prepared one month 
prior. 
Note 2:  SPE 6 utilized PNT/HRP solution prepared two months 
prior. 
Note 3:  Peak Average, Standard Deviation, and Result Average 
were calculated using all six SPEs. 
The forty percent concentration experiment utilized three PNT/HRP formula to 
investigate/determine the role of HRP and perhaps boost sensor sensitivity in the process.  
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The first four electrodes utilized a new batch of HRP solution while electrodes 5 and 6 
utilized PNT/HRP solutions that developed for previous tests.  This experiment appears to 
indicate HRP aging has a significant role in BSChE/BSCh sensitivity.  Based on this 
inhibition curve for malathion, detection of malathion at concentrations lower than 6 ppbv 
is likely achievable. 
 
Figure B-20: Combined Inhibition Curve for Twenty Five Percent Malathion 
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Figure B-21:  CV Combined Inhibition Curve for Forty Percent Concentration 
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B-11 Sensitivity Experiments with Ten, Forty, and Fifty Percent Concentration: 
On 15, 16, 21 Oct, and 3 Nov a set of six electrodes were prepared according to 
Table B-25 for the purpose of determining the sensitivity at ten, forty, fifty, and seventy-
five percent concentration, respectively.  Twelve 40ml vials were prepared the day prior 
day using malathion vapor gas at 25 ppbv combined with nitrogen gas to achieve the 
appropriate gas vapor concentration for each experiment.   
Table B-25:  Experiments with Malathion at Varied Concentration: 
 
Surface 
Preparation: 
Six electrodes prepared with cleaning solution.  
HRP encapsulated PNTs applied to surface and allowed to dry. 
BChE mid-layer added to three electrodes. 
After each application, electrodes were dried using nitrogen. 
 
Biosensor 
Conditioning: 
Initial immersion into phosphate buffer solution. 
Cyclic voltammeter (CV #1) test applied. 
Immersed in BSCh solution and CV #2 applied. 
Gas Phase 
Exposure: 
Inserted into 25 ppbv Malathion gas vapor for two minutes. 
CV #3 applied. 
Inhibition 
Measurement: 
Immediately re-inserted into BSCh solution. 
Applied CV #4 test.   
 
Analysis of the CV signatures for BSCh indicate inhibition.  See Figures B-22 
through B-25 for additional detail.  Tables B-26 through B-30 summarize malathion 
inhibition.  The ten percent concentration experiment utilized newly created PNT/HRP 
formula to investigate/determine the role of HRP and perhaps boost SPE sensitivity in the 
process.  This experiment appears to confirm HRP aging has a significant role in 
BSChE/BSCh sensitivity.  Based on this inhibition curve test for malathion, detection of 
malathion at concentrations lower than 6 ppbv is achievable. 
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Figure B-22:  BChE/BSCh Biosensor with Ten Percent Malathion Exposure 
Table B-26:  BChE Inhibition Peak with 10% Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.35 45.93 
2 -0.32 through -0.35 33.96 
3 -0.32 through -0.34 40.64 
4 -0.33 through -0.35 28.65 
5 -0.32 through -0.33 23.44 
6 -0.32 through -0.34 12.61 
Average -0.32 through -0.33 31.05 
Peak Average 
Std Dev 
 
 
30.87 
12.04 
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Table B-27:  BChE Inhibition Peak with Forty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.31 through -0.34 36.26 
2 -0.33 through -0.34 13.95 
3 -0.33 through -0.34 29.58 
4 -0.32 through -0.35 21.86 
5 -0.32 through -0.35 20.80 
6 -0.32 through -0.34 34.36 
Result Average -0.32 through -0.34 25.54 
Peak Average 
Std Dev 
 
 
26.14 
8.69 
 
 
 
Figure B-23:  BChE/BSCh Biosensor with Forty Percent Malathion Exposure 
-20
-10
0
10
20
30
40
50
60
70
80
90
-0.0003
-0.00028
-0.00026
-0.00024
-0.00022
-0.0002
-0.00018
-0.00016
-0.00014
-0.00012
-0.0001
-0.00008
-0.00006
-0.00004
-0.00002
0
0.00002
0.00004
0.00006
-0.8-0.7-0.6-0.5-0.4-0.3-0.2-0.100.10.20.30.40.50.60.70.80.91
St
an
d
ar
d
iz
ed
 R
at
io
: (
D
if
f(
P
re
-m
in
u
s 
P
o
st
)/
(1
.1
07
E
-0
6)
)
C
u
rr
e
n
t 
(A
)
Potential (V)
BChE Experiment With 40% Malathion Exposure - 10 ppbv
Average Pre-Malathion
Average Post Malathion Exposure
Diff (Pre- Minus Post) Malathion
21 Oct, 40% Concentration - (5 SPEs Average)
Area of Interest 
 
72 
 
Table B-28:  BChE Inhibition Peak with Forty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.34 34.27 
2 -0.32 through -0.33 28.77 
3 -0.32 through -0.34 40.05 
4 -0.33 through -0.34 29.56 
5 -
1
 -
1
 
6 -0.32 through -0.35 40.68 
Result Average -0.32 through -0.34 34.54 
Peak Average 
Std Dev 
 
 
34.67 
5.62 
Note 1:  CV response curves for this electrode was non-consistent 
and unusable. 
 
Table B-29:  BChE Inhibition Peak with Fifty Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.33 37.63 
2 -0.33 through -0.34 36.68 
3 -0.32 through -0.34 33.80 
4 -0.32 through -0.33 29.34 
5 -0.32 through -0.35 39.90 
6 -0.33 through -0.34 24.92 
Result Average -0.32 through -0.34 33.50 
Peak Average 
Std Dev 
 
 
33.71 
5.64 
 
 
Table B-30:  BChE Inhibition Peak with Seventy Five Percent Malathion 
Electrode # Potential (V) Inhibition (%) 
1 -0.32 through -0.35 52.01 
2 -0.33 through -0.35 56.74 
3 -0.32 through -0.36 58.06 
4 -0.32 through -0.35 53.60 
5 -0.32 through -0.35 53.86 
6 -0.33 through -0.35 54.03 
Result Average -0.33 through -0.35 54.42 
Peak Average 
Std Dev 
 
 
54.72 
2.24 
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Figure B-24:  BChE/BSCh Biosensor with Fifty Percent Malathion Exposure 
 
Figure B-25:  BChE/BSCh Biosensor with Seventy-Five Percent Malathion Exposure 
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Appendix C.  Longevity Exposure Experiments 
Although the Week 0 experiment was conducted on 5 Sep, the electrodes for the 
following weeks were prepared on 3 Sep and tested every seven days thereafter.  While 
tables C-1 and C-4 summarize the first longevity data set, tables C-5 and C-6 incorporate 
additional longevity test data from a second longevity test run.   
Table C-1.  Longevity Exposure Experiment Week 1 and 2 
Electrode 
# 
Week 1 – 10 Sep 13 Week 2 - 17 Sep13 
Potential (V) Inhibition 
(%) 
Potential (V) Inhibition 
(%) 
1 -0.32 to -0.36 82.60
1
 -0.31 to -0.33 49.75 
2 -0.36 to -0.37 72.37 -0.36 to -0.37 62.11 
3 -0.33 to -0.34 52.41 -0.35 to -0.36 51.95 
4 -0.31 to -0.32 54.05 -0.39 to -0.40 50.24 
5 -0.38 to -0.39 53.65 -0.38 to -0.39 45.85 
6 -0.41 to -0.42 50.68 -0.37 to -0.38 61.89 
Result  -0.34 to -0.35 52.95
1
 -0.36 to -0.37 50.93 
Average
2
 
Std Dev 
 
56.63
1
 
8.90 
 
53.63 
6.78 
Note 1:  Week 1, electrode 1 was excluded from data analysis due to likely 
liquid malathion exposure during CV #3 test for that electrode.   
Note 2:  The first Result Average value is a point by point averaging of the 
electrode values along the CV curve.  The second Result Average value 
is the straight value associated with the inhibition peak without respect 
to the potential along the CV curve. 
 
Figures C-1 and C-2 are full CV curve plots for the longevity experiments for the 
first four weeks.  The data lines plotted in the upper section of the graph belong to the 
y-axis labels indexed on the right hand side and demonstrate how the difference calculation 
was performed.  The data lines plotted in the lower section of the graph belong to the y-axis 
labels on the left hand side of the graph.  In order to compare the weekly results on a 
standardized graph, the weekly difference calculation was divided by 1.1066X10
-06
 so that 
a weekly standardized comparison could be made.   
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Table C-2:  Longevity Exposure Experiment Week 3 and 4 
Electrode 
# 
Week 3 – 24 Sep 13 Week 4 - 1 Oct 13 
Potential (V) Inhibition 
(%) 
Potential (V) Inhibition (%) 
1 -0.33 to -0.34 58.69 -0.36 to -0.37 49.36 
2 -0.34 to -0.35 67.79 -0.35 to -0.35 44.34 
3 -0.33 to -0.35 68.84 -0.34 to -0.35 60.81 
4 -0.35 to -0.37 78.10 -0.37 to -0.38 42.12 
5 -0.34 to -0.37 72.58 -0.35 to -0.37 50.15 
6 -0.36 to -0.38 66.29 -0.37 to -0.38 51.64 
Result -0.34 to -0.36 68.23 -0.35 to -0.37 49.18 
Average 
Std Dev 
 
68.72 
6.48 
 
49.74 
6.54 
Note:  Week 3, BSCE/BSCh electrodes indicates higher inhibition.  Although there 
are multiple possible reasons for improved inhibition compared to Week 1 
and 2 data, the strongest likelihood is that decreasing the delay between 
Malathion, CV#3, exposure and CV#4 retesting of the electrode resulted in 
higher inhibition measurement. 
 
 
Figure C-1: Longevity Test Week One and Two 
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Figure C-2: Longevity Test Week Three and Four 
There was one notable exception made during the comparison of individual 
electrode results that resulted in the exclusion of one data set.  Upon data review, see 
Figure C-3, the CV data curve plotted during malathion exposure indicated that the 
electrode was either immersed in malathion or was still wet from the previous PB test and 
initial baseline BSCh immersion.  Since this was not part of the standard protocol for gas 
phase detection, the data was excluded from further gas phase detection analysis. 
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Figure C-3: Malathion Exposure: BSCh Longevity Week 1, Electrode 1 Data Anomaly 
After reviewing the area of interest in Figures C-4 through C-5, tables C-3 and C-4 
record the percent of malathion inhibition measured for Longevity Week’s 5, 6, 8, 10, and 
11.  Individual electrode information was averaged to arrive at CV summary curve 
information. 
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data analysis. 
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Figure C- 4: Longevity Test Week Five and Six 
 
Figure C- 5: Longevity Test Week Eight, Ten and Twelve 
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Table C-3:  Longevity Exposure Experiment Week 5 and 6 
Electrode 
# 
Week 5 – 16 Oct 13 Week 6 - 15 Oct 13 
Potential (V) Inhibition (%) Potential (V) Inhibition (%) 
1 -0.34 to -0.35 54.78 -0.32 to -0.34 65.34 
2 -0.36 to -0.37 53.95 -0.34 to -0.35 65.04 
3 -0.33 to -0.39 58.47 -0.34 to -0.36 61.54 
4 -0.34 to -0.37 66.67 -0.33 to -0.35 64.99 
5 -0.37 to -0.38 61.79 -0.35 to -0.37 59.25 
6 -0.37 to -0.38 60.90 -0.35 to -0.36 38.63
*
 
Result  -0.35 to -0.37 58.98 -0.34 to -0.35 58.35 
Average 
Std Dev 
 
59.43 
4.75 
 
63.23 
2.72 
Note:  Analysis of CV curve electrode data indicates the biosensor surface may have 
been abraded during the test protocol series resulting in an erroneous inhibition 
result. 
 
Inhibition is related to the amount of malathion concentration and the duration of 
exposure.  Measured inhibition is also influenced by BChE “recovery:” a delay in the 
amount of time between exposure and the follow up test results in an inability to fully 
capture the inhibition.  The BChE/BSCh chemical reaction is reversible; when BChE is no 
longer exposed to malathion, inhibition moves toward the non-exposure, equilibrium state. 
Table C-4:  Longevity Exposure Experiment Week 8, 10 and 12 
Electrode 
# 
Week 8 – 29 Oct 13 Week 10/11 – 12/16 Nov 13
1
 
Potential (V) Inhibition (%) Potential (V) Inhibition (%) 
1 -0.33 to -0.34 76.29 -0.36 to -0.37 39.04 
2 -0.34 to -0.35 82.50 -0.35 to -0.35 55.30 
3 -0.33 to -0.35 75.01 -0.34 to -0.35 33.82 
4 -0.35 to -0.37 82.48 -0.37 to -0.38 3.98 
5 -0.34 to -0.37 72.18 -0.35 to -0.36 39.17 
6 -0.36 to -0.38 72.72 -0.37 to -0.38 51.06 
Result  -0.34 to -0.36 76.61 -0.32 to -0.35 31.24 
Average 
Std Dev 
 
76.86 
4.60 
 
31.40 
8.41 
Note:  After analysis of longevity week 8 results, it was determined that electrode 
degradation would likely not provide usable results if the longevity test was 
carried to week 12.  Electrodes 1, 2, and 4 were tested on week 10.  Electrodes 4, 
5, and 6 were measured on week 11. 
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Additional Longevity Experiments - 26 Oct 13 through 16 Nov 13 
The following data incorporates a second data set of longevity experiments that was 
collected.  As is noted in the comment section of the tables, the two data sets were 
combined using statistical pooled average and pooled standard deviation calculations.  The 
longevity test results were consistent. 
Table C-5:  Longevity Exposure Experiment Week 1 and 2 
Electrode 
# 
Week 1 – 26 Oct 13 Week 2 - 2 Nov13 
Potential (V) Inhibition (%) Potential (V) Inhibition (%) 
1 -0.33 to -0.35 69.67 -0.32 to -0.35 63.27 
2 -0.32 to -0.35 64.66 -0.37 to -0.38 32.21 
3 -0.32 to -0.33 48.86 -0.37 to -0.38 56.29 
4 -0.33 to -0.36 51.23 -0.34 to -0.35 60.24 
5 -0.33 to -0.36 59.16 -0.34 to -0.35 63.25 
6 -0.32 to -0.35 -
3
 -0.36 to -0.37 53.03 
Result  -0.32 to -0.36 58.02 -0.34 to -0.36 53.79 
Average
1 
Std Dev 
56.63 
8.90 
58.72 
8.78 
53.63 
6.78 
54.72 
11.73 
Pooled 
Average
1
 
57.68 54.17 
Pooled 
Std Dev
2
 
8.84 9.58 
Note 1:  Pooled Average is the average of all samples taken in each set divided by the 
number of samples. 
Note 2:  Pooled Standard Deviation = √ (Sp
2
) = √{[(n1-1)s1
2
+(n2-1)s2
2
+ …(nk-1)sk
2
] / [n1+ 
n2+ … nk - k)]} 
Note 3:  CV Curve was non-consistent and unusable. 
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Table C-6: Longevity Exposure Experiment Week 3 and 4 
Electrode 
# 
Week 3 – 9 Nov 13 Week 4 - 16 Nov 13 
Potential (V) Inhibition (%) Potential (V) Inhibition (%) 
1 -0.32 to -0.35 66.15 -0.32 to -0.35 47.6 
2 -0.32 to -0.35 61.70 -0.32 to -0.35 43.16 
3 -0.32 to -0.35 -
3
 -0.32 to -0.35 37.59 
4 -0.32 to -0.35 50.89 -0.32 to -0.35 23.59 
5 -0.32 to -0.35 55.43 -0.32 to -0.35 58.23 
6 -0.32 to -0.35 56.79 -0.32 to -0.35 57.29 
Result  -0.32 to -0.35 58.19 -0.32 to -0.35 44.41 
Average 
Std Dev 
68.72 
6.48 
58.19 
5.89 
49.74 
6.54 
44.58 
13.03 
Pooled 
Average
1
 
63.93 47.16 
Pooled 
Std Dev
2
 
6.22 10.31 
Note 1:  Pooled Average is the average of all samples taken in each set divided by the 
number of samples. 
Note 2:  Pooled Standard Deviation = √ (Sp2) = √ {[(n1-1)s1
2
+(n2-1)s2
2
+ …(nk-1)sk
2
] / 
[n1+ n2+ … nk - k)]} 
Note 3:  CV Curve was non-consistent and unusable. 
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Appendix D.  Chemical/Materials Ordering List 
Table D-1:  Material List, Amount, and Manufacturer Source 
Chemical Type 
HAZ Code 
CAS Number 
Product # 
Manufacturer Additional Info 
ASCh-Chloride 
HAZ B (213089) 
60-31-1 
A6635 
Sigma Aldrich 
St. Louis, MO 
>99% TLC 25G $40.60 
1001053000 
AChE-type V-S  
from electric eel 
HAZ B (213069) 
9000-81-1 
C2888 
Sigma Aldrich 
Milwaukee, WI 
500UN $78.00 
1001165276 
Horseradish Peroxidase (HRP) 
 HAZ B (213103) 
9003-99-0 
P8250 
Sigma Aldrich 
Milwaukee, WI 
5KU $43.48 
 
Butyrylthiocholine (BSCh) 
HAZ B (216566) 
22026-63-7 
B3128 
Sigma Aldrich 
St. Louis, MO 
1G  $102.00 
  
Butyrylcholinesterase 
(BChE) 
HAZ A (216568) 
9001-08-5 
C1057 
C4290 
Sigma Aldrich 
St. Louis, MO 
1KU $244.56 
1KU $210.00 
Cellulose acetate 
HAZ A (216567) 
9004-35-7 
180955 
Sigma Aldrich 
St. Louis, MO 
25G  $37.60 
500G  $74.50 
Malathion >95% 
HAZ C (214175) 
121-75-5 
36143 
91481 
Sigma Aldrich 
Milwaukee, WI 
100MG  $33.90 
50MG  $77.10 
H-Phe-Phe-OH 
(DI-L-Phenylalanine) 
HAZ C (213072) 
150-30-1 
147966 
Sigma Aldrich 
St. Louis, MO 
101069369 
25G  $30.80 
1,1,1,3,3,3-hexafluoro-2-propanol 
(99.8% purity) 
HAZ B (213090) 
920-66-1 
105228 
Sigma Aldrich 
Milwaukee, WI 
>99% 25G  $85.74 
Nafion© 117  
solution (approx. 5%) 
31175-20-9 
309389 
Sigma Aldrich 
Allentown, PA 
25G $258.50 
Deionized water - 
AFIT Lab 
Dayton, OH 
 
Ammonium acetate 
HAZ A (203063) 
631-61-8 
A1542 
Sigma Aldrich 
Allentown, PA 
250G $31.00 
Potassium phosphate dibasic 
HAZ B (153837) 
7758-11-4 
P3786 
Sigma Aldrich 
Allentown, PA 
1KG  $105.09 
Gold SPEs model DRP-250 
(a 4-mm-diameter gold) 
N/A 
Metrohm USA 
Riverview, FL 
Mike Kubicsko 
516-644-0354 
Electrode-Potentiostat interface cable N/A 
Metrohm USA 
Riverview, FL 
 
Jacketed Compact Voltammeter Cell N/A 
Pine Research Instrumentation 
Durham, NC 
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